FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
This Quarter Return
+21.72%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
AUM
$457M
AUM Growth
+$457M
Cap. Flow
-$40M
Cap. Flow %
-8.75%
Top 10 Hldgs %
83.5%
Holding
23
New
Increased
2
Reduced
9
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$115M 24.85% 1,708,046 -242,431 -12% -$16.4M
IMMU
2
DELISTED
Immunomedics Inc
IMMU
$60.2M 12.96% 2,541,729 -158,271 -6% -$3.75M
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$46.5M 10.01% 2,942,130
RCUS icon
4
Arcus Biosciences
RCUS
$1.13B
$42.2M 9.08% 3,445,461
AKAO
5
DELISTED
Achaogen, Inc.
AKAO
$24.9M 5.36% 2,874,418 +24,418 +0.9% +$211K
AIMT
6
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$22.9M 4.93% 851,213 -83,807 -9% -$2.25M
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$21M 4.51% 1,562,040
MYOK
8
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$19.5M 4.2% 392,789
BPMC
9
DELISTED
Blueprint Medicines
BPMC
$15.9M 3.42% 250,000 -150,000 -38% -$9.52M
XLRN
10
DELISTED
Acceleron Pharma Inc.
XLRN
$13.5M 2.91% 278,753
EPZM
11
DELISTED
Epizyme, Inc
EPZM
$12.7M 2.74% 940,685 -57,593 -6% -$780K
ASND icon
12
Ascendis Pharma
ASND
$11.8B
$12.7M 2.74% 191,588 -110,421 -37% -$7.34M
BOLD
13
DELISTED
Audentes Therapeutics, Inc
BOLD
$12M 2.59% 315,331
SLDB icon
14
Solid Biosciences
SLDB
$427M
$12M 2.59% 337,884
VRNA
15
Verona Pharma
VRNA
$9.16B
$6.87M 1.48% 502,825 -62,467 -11% -$853K
ACRS icon
16
Aclaris Therapeutics
ACRS
$209M
$6.24M 1.34% 312,368
BHVN
17
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.18M 0.9% 105,706
SGMO icon
18
Sangamo Therapeutics
SGMO
$157M
$3.77M 0.81% 265,605 +111,143 +72% +$1.58M
WVE icon
19
Wave Life Sciences
WVE
$1.53B
$2.87M 0.62% 75,000
FBRX icon
20
Forte Biosciences
FBRX
$137M
$1.39M 0.3% 148,552
ARDX icon
21
Ardelyx
ARDX
$1.53B
$482K 0.1% 130,304 -73,288 -36% -$271K
BDSI
22
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$58K 0.01% 19,500 -130,504 -87% -$388K
RARX
23
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-50,000 Closed -$266K